“There was a 27% smaller reduction in LDL cholesterol with atorvastatin treatment in low cholesterol synthesisers with high absorption, defined by changes at or above the median lanosterol and campesterol levels , respectively, compared with the obverse group (difference 0.42 mmol/l [0.21, 0.62]).”